AU-007 routine has entered a section 2 melanoma trial, with early information displaying exercise and manageable security.The primary affected person has been dosed...
The FDA beforehand granted breakthrough remedy designation to ziftomenib for relapsed/refractory NPM1-mutant acute myeloid leukemia.A New Drug Utility (NDA) has been submitted to...
April is Testicular Most cancers Consciousness Month, in keeping with the Testicular Most cancers Consciousness Basis, and since testicular most cancers is the...
The U.S. Meals and Drug Administration (FDA) has authorized Cabometyx (cabozantinib) for some sufferers 12 years of age and older with beforehand handled...
